This Cochrane review protocol outlines a plan to evaluate whether reducing or discontinuing conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) is...
Read moreDetailsThis Cochrane review protocol outlines a plan to evaluate whether reducing or discontinuing conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) is...
Read moreDetailsA comprehensive review of 592 prediction models designed to estimate radiation-induced side effects in patients with head and neck cancer...
Read moreDetailsThis Cochrane review protocol outlines plans to evaluate whether once-daily or twice-daily radiotherapy, when combined with chemotherapy, offers better survival...
Read moreDetails